A REPETITIVE INTRACRANIAL INJECTION OF NATURAL KILLER CELLS ENGINEERED WITH A HER2-TARGETED CHIMERIC ANTIGEN RECEPTOR ALONE AND IN COMBINATION WITH SYSTEMIC ANTI-PD-1 CHECKPOINT INHIBITION IN PATIENTS WITH RECURRENT GLIOBLASTOMAM. C. Burger, E. Ehrend,F. Strassheimer,P. Cakmak,H. Krenzlin, P. Elleringmann,P. S. Zeiner, S. C. Herkt,I Poschke,J. Macas, K. J. Weber, J. Schupp, J. H. Lun, C. Opitz,B. Roller, P. Manns, S. Klinsing, S. Breuer,S. Hehlgans, S. Lee,I. C. Mildenberger, G. Ludmirski, J. Hermann, E. Mueller, M. Schmitz, M. Mehlitz,C. Senft,P. N. Harter, M. A. Rieger,F. Roedel,M. Czabanka,M. Ratliff,M. Platten,C. Herold-Mende,F. Ringel,E. Herrmann,E. Hattingen,Y. Reiss,L. Bunse,H. Bonig,K. H. Plate,M. Forster,T. Tonn,W. S. Wels,J. P. SteinbachNEURO-ONCOLOGY(2024)Cited 0|Views3AI Read ScienceMust-Reading TreeExampleGenerate MRT to find the research sequence of this paperChat PaperSummary is being generated by the instructions you defined